These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 33612058)

  • 21. Iris hyperpigmentation in a Chinese family with ocular albinism and the GPR143 mutation.
    Xiao X; Zhang Q
    Am J Med Genet A; 2009 Aug; 149A(8):1786-8. PubMed ID: 19610097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ophthalmic features of minimal pigment oculocutaneous albinism.
    Summers CG; King RA
    Ophthalmology; 1994 May; 101(5):906-14. PubMed ID: 8190479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic Causes of Oculocutaneous Albinism in Pakistani Population.
    Sajid Z; Yousaf S; Waryah YM; Mughal TA; Kausar T; Shahzad M; Rao AR; Abbasi AA; Shaikh RS; Waryah AM; Riazuddin S; Ahmed ZM
    Genes (Basel); 2021 Mar; 12(4):. PubMed ID: 33800529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comprehensive genetic study of autosomal recessive ocular albinism in Caucasian patients.
    Hutton SM; Spritz RA
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):868-72. PubMed ID: 18326704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequence analysis of tyrosinase gene in ocular and oculocutaneous albinism patients: introducing three novel mutations.
    Khordadpoor-Deilamani F; Akbari MT; Karimipoor M; Javadi G
    Mol Vis; 2015; 21():730-5. PubMed ID: 26167114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NGS-based targeted sequencing identified two novel variants in Southwestern Chinese families with oculocutaneous albinism.
    Xiao Y; Zhou C; Xie H; Huang S; Wang J; Liu S
    BMC Genomics; 2022 Apr; 23(1):332. PubMed ID: 35488210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nystagmus and Foveal Hypoplasia in a Carrier of Oculocutaneous Albinism.
    Arora N; Hoyek S; Patel NA
    Ophthalmic Surg Lasers Imaging Retina; 2024 Jun; 55(6):349-353. PubMed ID: 38860972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Insights Into Foveal Morphology in Albinism.
    McCafferty BK; Wilk MA; McAllister JT; Stepien KE; Dubis AM; Brilliant MH; Anderson JL; Carroll J; Summers CG
    J Pediatr Ophthalmol Strabismus; 2015; 52(3):167-72. PubMed ID: 26053207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Five Novel Variants in Chinese Oculocutaneous Albinism by Targeted Next-Generation Sequencing.
    Qiu B; Ma T; Peng C; Zheng X; Yang J
    Genet Test Mol Biomarkers; 2018 Apr; 22(4):252-258. PubMed ID: 29437493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evident hypopigmentation without other ocular deficits in Dutch patients with oculocutaneous albinism type 4.
    Kruijt CC; Schalij-Delfos NE; de Wit GC; Florijn RJ; van Genderen MM
    Sci Rep; 2021 Jun; 11(1):11572. PubMed ID: 34078970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of oculocutaneous albinism with molecular analysis.
    Summers CG; Oetting WS; King RA
    Am J Ophthalmol; 1996 Jun; 121(6):724-6. PubMed ID: 8644824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotypic and Phenotypic Spectrum of Foveal Hypoplasia: A Multicenter Study.
    Kuht HJ; Maconachie GDE; Han J; Kessel L; van Genderen MM; McLean RJ; Hisaund M; Tu Z; Hertle RW; Gronskov K; Bai D; Wei A; Li W; Jiao Y; Smirnov V; Choi JH; Tobin MD; Sheth V; Purohit R; Dawar B; Girach A; Strul S; May L; Chen FK; Heath Jeffery RC; Aamir A; Sano R; Jin J; Brooks BP; Kohl S; Arveiler B; Montoliu L; Engle EC; Proudlock FA; Nishad G; Pani P; Varma G; Gottlob I; Thomas MG
    Ophthalmology; 2022 Jun; 129(6):708-718. PubMed ID: 35157951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational Analysis of TYR, OCA2, and SLC45A2 Genes in Chinese Families with Oculocutaneous Albinism.
    Lin Y; Chen X; Yang Y; Che F; Zhang S; Yuan L; Wu Y
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00687. PubMed ID: 31199599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spectrum of candidate gene mutations associated with Indian familial oculocutaneous and ocular albinism.
    Renugadevi K; Sil AK; Perumalsamy V; Sundaresan P
    Mol Vis; 2010 Aug; 16():1514-24. PubMed ID: 20806075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microarray analysis of iris gene expression in mice with mutations influencing pigmentation.
    Trantow CM; Cuffy TL; Fingert JH; Kuehn MH; Anderson MG
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):237-48. PubMed ID: 20739468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variable expression of vision in sibs with albinism.
    Summers CG; Creel D; Townsend D; King RA
    Am J Med Genet; 1991 Sep; 40(3):327-31. PubMed ID: 1951438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TYR mutation in a Chinese population with oculocutaneous albinism: Molecular characteristics and ophthalmic manifestations.
    Chen C; Li J; Wang B; Wang Y; Yu X
    Exp Eye Res; 2024 Feb; 239():109761. PubMed ID: 38145795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism.
    Lee ST; Nicholls RD; Bundey S; Laxova R; Musarella M; Spritz RA
    N Engl J Med; 1994 Feb; 330(8):529-34. PubMed ID: 8302318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oculocutaneous albinism (OCA) in Colombia: first molecular screening of the TYR and OCA2 genes in South America.
    Urtatiz O; Sanabria D; Lattig MC
    J Dermatol Sci; 2014 Dec; 76(3):260-2. PubMed ID: 25455140
    [No Abstract]   [Full Text] [Related]  

  • 40. Novel GPR143 mutations and clinical characteristics in six Chinese families with X-linked ocular albinism.
    Fang S; Guo X; Jia X; Xiao X; Li S; Zhang Q
    Mol Vis; 2008; 14():1974-82. PubMed ID: 18978956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.